BioSpace News Archive

The report highlights trends prevailing in the global respiratory ventilator tester market, and the drivers and restraints pertaining to the market growth.

The report highlights the trends prevalent in the market and the factors driving the market along with those that

Thousands of content creators from around the world joined St. Jude PLAY LIVE® to raise a record-breaking more than $4 million for St. Jude Children’s Research Hospital® in May by grabbing their controllers to entertain a live audience while raising awareness and support for the lifesaving mission of St. Jude: Finding cures.

The report highlights the trends prevailing in the market, along with market drivers and deterrents.

Vynca, a national leader in advance care planning, today announced that it has acquired California-based ResolutionCare, an innovator and provider of home-based palliative care and telemedicine.

Results of two new studies illustrate continued momentum for Dexcom CGM, including JAMA-published data on additional populations who can benefit from the technology

The scientific papers, presenting preclinical and clinical Phase I/II results for TOTUM•63, have been accepted and published in three international peer-reviewed journals: the American Journal of Physiology-Endocrinology and Metabolism, the International Journal of Obesity and Nutrients

miR Scientific, LLC, a healthcare company dedicated to transforming global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be presenting at the Jefferies Virtual Healthcare Conference.

GoMeyra, announced today that they will become technology partner to KSL Biomedical, Inc., developers of novel companion diagnostic and therapeutic applications for immunology and oncology, along with its clinical laboratory subsidiary, KSL Diagnostics, Inc. (www.ksldx.com).

Novartis today announced that results of the Phase III VISION study evaluating 177Lu-PSMA-617, a targeted radiological therapy.